Excess salt cuts energy supply of immune regulators

Too much salt can disrupt the energy metabolism in regulatory immune cells

Eating too much salt is not only bad for our blood pressure and cardiovascular system. It could also impact the immune system. An international research team, coordinated by scientists at VIB and Hasselt University (Belgium), as well as the Max Delbrück Center in Berlin (Germany), now reports in Cell Metabolism that salt can disturb important immune regulators called regulatory T cells by upsetting their energy metabolism. The findings may provide new avenues to explore the development of autoimmune and cardiovascular diseases.  

A few years ago, research by the teams of Prof. Dominik Mueller at the Max Delbrück Center for Molecular Medicine and the Experimental and Clinical Research Center, a joint institution of Charité – Universitätsmedizin Berlin in Germany, and Prof. Markus Kleinewietfeld of the VIB Center for Inflammation Research & Hasselt University, Belgium, and colleagues revealed that too much salt in our diet, common in many Western societies, can disrupt the metabolism and energy balance in innate immune cells, called monocytes/macrophages, which stops them from working properly. They showed that salt induces malfunctions in the mitochondria, the power plants in our cells. Inspired by these findings, the research groups wondered whether excessive salt also creates a similar problem in adaptive immune cells, like regulatory T cells. 

Important immune regulators 

Regulatory T cells, also known as Tregs, are an essential part of the adaptive immune system and they are responsible for maintaining the balance between normal function and unwanted, overreaching inflammation. They are sometimes referred to as the 'immune police' that keep the bad guys (autoreactive immune cells) at bay and ensure that immune responses happen in a controlled way without harming the host organism. ​ 

The deregulation of Tregs is believed to be linked to the development of autoimmune diseases, like multiple sclerosis. Interestingly, recent research observed problems in mitochondrial function of Tregs from patients with autoimmunity but contributing factors remained elusive. ​ 

Prof. Dominik Mueller (Max Delbrück Center and the Experimental and Clinical Research Center in Berlin, Germany) explains: "Considering our previous findings of salt affecting the mitochondrial function of monocytes/macrophages and the new observations on mitochondria in autoimmune Tregs, we were wondering if sodium may elicit similar issues in Tregs." ​ 
(Felix Petermann, Max Delbrück Center)

Salt interferes with mitochondrial function of Tregs  

Previous research has already shown that excess salt could impact Treg function by inducing an autoimmune-like phenotype. In other words, too much salt makes the Treg cells look like those involved in autoimmune conditions. However, the exact way sodium impairs Treg function has not been uncovered. ​ 

The new international study led by Prof. Kleinewietfeld and Prof. Mueller and first authored by Drs. Beatriz Côrte-Real and Ibrahim Hamad (VIB Center for Inflammation Research & Hasselt University, Belgium), now discovered that sodium disrupts Treg function by altering cellular metabolism through interference with mitochondrial energy generation. This mitochondrial problem seemed to be the initial step in how salt alters Treg function, leading to changes in gene expression that showed similarities to those of dysfunctional Tregs in autoimmune conditions. ​ 

Even a short-term disruption of mitochondrial function showed long-lasting consequences for the fitness and immune-regulating capacity of Tregs in experimental models. The new findings suggest that sodium may be a factor that could contribute to Treg dysfunction, potentially playing a role in different diseases, although this needs to be confirmed in further studies. 

Prof. Markus Kleinewietfeld
Prof. Markus Kleinewietfeld (VIB Center for Inflammation Research & Hasselt University, Belgium): “The better understanding of factors and underlying molecular mechanisms contributing to Treg dysfunction in autoimmunity is an important question in the field. Since Tregs also play a role for example in cancer or cardiovascular diseases, the further exploration of those sodium-elicited effects may offer novel strategies to alter Treg function in different types of diseases. However, future studies are needed to understand the molecular mechanisms in more detail and to clarify their potential relation to disease.” 

Publication 

Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs. Côrte-Real, Hamad, et al. Cell Metabolism, 2023. doi: 10.1016/j.cmet.2023.01.009


Questions from patients

A breakthrough in research is not the same as a breakthrough in medicine. The realizations of VIB researchers can form the basis of new therapies, but the development path still takes years. This can raise a lot of questions. That is why we ask you to please refer questions in your report or article to the email address that VIB makes available for this purpose: patienteninfo@vib.be. Everyone can submit questions concerning this and other medically-oriented research directly to VIB via this address.


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be